Spruce Biosciences (SPRB) Debt Ratio (2019 - 2026)
Spruce Biosciences (SPRB) posted quarterly Debt Ratio of 0.12 for Q1 2026, up 170.81% year-over-year from 0.04 in Q1 2025, and up 226.96% quarter-over-quarter from 0.04 in Q3 2025.
Spruce Biosciences (SPRB) Debt Ratio (2019 - 2026) Analysis & Trends
Spruce Biosciences (SPRB) has reported Debt Ratio for 8 consecutive years, with 0.12 the latest figure, recorded in Q1 2026.
- In Q1 2026, Debt Ratio rose 170.81% year-over-year to 0.12; the TTM figure through Mar 2026 stood at 0.12 (up 170.81% YoY), while the FY2024 annual figure was 0.04, up 20.23% from the prior year.
- Debt Ratio climbed to 0.12 in Q1 2026 per SPRB's latest filing, from 0.04 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.12 in Q1 2026 and bottomed at 0.03 in Q4 2023.
- Historically, Debt Ratio has averaged 0.04 across 5 years, with a median of 0.04 in 2024.
- Annual changes were most pronounced in 2023 — Debt Ratio slumped 44.02% — and 2026, when it soared 170.81%.
- Spruce Biosciences' Debt Ratio stood at 0.06 in 2022, then plunged by 44.02% to 0.03 in 2023, then increased by 20.23% to 0.04 in 2024, then decreased by 8.86% to 0.04 in 2025, then surged by 226.96% to 0.12 in 2026.
- Business Quant data shows SPRB's Debt Ratio at 0.12 in Q1 2026, 0.04 in Q3 2025, and 0.04 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.99 Bn | 132.14 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.80 Bn | 78.80 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 65.38 Bn | 60.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.70 Bn | 55.56 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn | 0.03 |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | 0.26 |
| 9 | Royalty Pharma | 27.21 Bn | 26.37 Bn | - | 0.47 |
| 10 | Spruce Biosciences | 125.93 Mn | 125.93 Mn | - | 0.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.07 |
| Mar 31, 2026 | 0.12 |
| Sep 30, 2025 | 0.04 |
| Jun 30, 2025 | 0.04 |
| Mar 31, 2025 | 0.04 |
| Dec 31, 2024 | 0.04 |
| Sep 30, 2024 | 0.03 |
| Jun 30, 2024 | 0.03 |
| Mar 31, 2024 | 0.03 |
| Dec 31, 2023 | 0.03 |
| Sep 30, 2023 | 0.03 |
| Jun 30, 2023 | 0.03 |
| Mar 31, 2023 | 0.03 |
| Dec 31, 2022 | 0.06 |
| Sep 30, 2022 | 0.05 |
| Jun 30, 2022 | 0.05 |
| Mar 31, 2022 | 0.04 |
| Dec 31, 2021 | 0.04 |
| Sep 30, 2021 | 0.04 |
| Jun 30, 2021 | 0.03 |